SCHEMBL10026219

SCHEMBL10026219

COC(=O)c1cc(C(=O)OC)c2ccc3c(c2c1)C=CC(c1ccccc1)(c1ccccc1)O3

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.36
ALOX5 P09917 1/20 0.36
PTPN1 P18031 2/20 0.36
HIF1A Q16665 1/20 0.35
KDM4E B2RXH2 5/20 0.35
PDK2 Q15119 1/20 0.35
ALDH1A1 P00352 5/20 0.35
HPGD P15428 4/20 0.35
MEN1 O00255 2/20 0.35
TP53 P04637 2/20 0.35
GAA P10253 2/20 0.35
MAPT P10636 2/20 0.35
MAPK1 P28482 2/20 0.35
KMT2A Q03164 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
CASP1 P29466 1/20 0.35
CASP7 P55210 1/20 0.35
HSD17B10 Q99714 1/20 0.35
L3MBTL1 Q9Y468 1/20 0.35
PPARA Q07869 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13061587 0.84 ALOX5 (0.43) TSHRALOX5PTPN1KDM4EALDH1A1
SCHEMBL361912 0.83 LCK (0.45) TSHRALOX5PTPN1KDM4EALDH1A1
SCHEMBL5158009 0.75 ALDH1A1 (0.31) KDM4EALDH1A1HPGDMAPTHSD17B10
SCHEMBL1334076 0.74 MAPT (0.48) TSHRMEN1TP53GAAMAPT
SCHEMBL5647064 0.74 GAA (0.42) TSHRKDM4EALDH1A1MEN1GAA
SCHEMBL26290022 0.73 KDM4E (0.45) TSHRPTPN1KDM4EALDH1A1HPGD
SCHEMBL7128812 0.72 MAPT (0.40) KDM4EALDH1A1MEN1GAAMAPT
SCHEMBL5107478 0.72 NR4A2 (0.37) TSHRKDM4EALDH1A1HPGDMEN1
SCHEMBL4798246 0.71 PLA2G2A (0.41) TSHRALOX5KDM4EALDH1A1HPGD
SCHEMBL3238390 0.71 PLA2G2A (0.39) TSHRKDM4EPDK2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8500807-B2 Photochromic intraocular lens CARL ZEISS MEDITEC SAS (FR) 2013-08-06 US disclosed
US-8500807-B2 Photochromic intraocular lens CARL ZEISS MEDITEC SAS (FR) 2013-08-06 US disclosed
EP-1753838-B1 POLYMERISABLE NAPHTHOPYRAN DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM SAID DERIVATIVES POLYMEREXPERT S A (FR) 2012-03-14 EP disclosed
US-20100317805-A1 POLYMERISABLE NAPHTHOPYRANE DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM THESE DERIVATIVES POLYMEREXPERT (FR) 2010-12-16 US disclosed
EP-1834195-B9 PHOTOCHROMIC INTRAOCULAR LENS IOLTECHNOLOGIE PRODUCTION (FR) 2010-07-21 EP disclosed
EP-1834195-B1 PHOTOCHROMIC INTRAOCULAR LENS IOLTECHNOLOGIE PRODUCTION (FR) 2010-03-17 EP disclosed
US-20080200983-A1 Photochromic Intraocular Lens IOLTECHNOLOGIE-PRODUCTION (FR) 2008-08-21 US disclosed
US-20080200983-A1 Photochromic Intraocular Lens IOLTECHNOLOGIE-PRODUCTION (FR) 2008-08-21 US disclosed
US-20070197750-A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives POLYMEREXPERT (FR) 2007-08-23 US disclosed
US-20070197750-A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives POLYMEREXPERT (FR) 2007-08-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070197750-A1 Polymerisable naphthopyrane derivatives and polymer materials obtained from these derivatives CCND3, H1-3, H1-0 TSHR 4494/4885ALOX5 1758/4885PTPN1 3903/4885
US-20100317805-A1 POLYMERISABLE NAPHTHOPYRANE DERIVATIVES AND POLYMER MATERIALS OBTAINED FROM THESE DERIVATIVES C1S, H1-0, H1-3 TSHR 4627/4885ALOX5 1614/4885PTPN1 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.